Tesamorelin Peptide
Tesamorelin is a pharmaceutical-grade synthetic analog of growth hormone-releasing hormone (GHRH) specifically developed to reduce visceral adipose tissue. FDA-approved for HIV-associated lipodystrophy, this precision formulation stimulates endogenous growth hormone production while selectively targeting abdominal fat reduction and improving metabolic parameters without affecting subcutaneous adipose tissue.